Assistant Professor
Oncology
Dr. Crystal S. Denlinger, MD
|
|
Give Review
Crystal Denlinger is an expert in the field of Oncology. She attended Rutgers New Jersey Medical School. Rutgers New Jersey Medical School is ranked 76 in research and 0 in primary care medicine She has 2 awards "CMS Meaningful Use Stage 1 Certification" and "Fellow". Crystal Denlinger is a published doctor and has 22 publications published. The lastest was: 'Development and preliminary testing of PROGRESS: a Web-based education program for prostate cancer survivors transitioning from active treatment.' She accepts all Medicare patients.
Publications
- Development and preliminary testing of PROGRESS: a Web-based education program for prostate Cancer survivors transitioning from active treatment.
- Survivorship: tools for transitioning patients with Cancer.
- Erratum to: Phase II study of selumetinib (AZD6244, ARRY-142886) plus irinotecan as second-line therapy in patients with K-RAS mutated colorectal Cancer.
- Phase II study of selumetinib (AZD6244, ARRY-142886) plus irinotecan as second-line therapy in patients with K-RAS mutated colorectal Cancer.
- Optimizing surveillance and balancing evidence with patient expectations.
- A Work in Progress: Developing the New NCCN Guidelines for Survivorship.
- Survivorship: introDuction and definition.
- Neoadjuvant Chemoradiation and Duration of Chemotherapy Before Surgical Resection for Pancreatic Cancer: Does Time Interval Between Radiotherapy and Surgery Matter?
- New NCCN guidelines for survivorship care.
- Gastric Cancer, Version 2.2013.
- Occult primary.
- Significance of pathologic response to preoperative therapy in pancreatic Cancer.
- Esophageal and esophagogastric junction Cancers.
- Colorectal Cancer survivorship: movement matters.
- Defining venous involvement in borderline resectable pancreatic Cancer.
- The challenges of colorectal Cancer survivorship.
- Progress in the development of prognostic and predictive markers for gastrointestinal Malignancies.
- Pharmacokinetic Analysis of irinotecan plus bevacizumab in patients with advanced solid tumors.
- Challenges in the management of older patients with colon Cancer.
- Gastric Cancer.
- Impact of the Radiation Boost on Outcomes After Breast-Conserving Surgery and Radiation.
Schools
UmdnjNew Jersey Medical School
Conditions Treated
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- Bile Duct Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow
Education
-
Temple University Hospital -
Mount Sinai School of Medicine -
Rutgers New Jersey Medical School
Hospital
-
Fox Chase Cancer Center-American Oncologic Hospital -
Temple University Hospital
Drug Facts
| NPI NUMBER | 1063626190 | |
| NPPES Provider LastName | DENLINGER | |
| NPPES Provider FirstName | CRYSTAL | |
| NPPES Provider ZIPCode | 191112434 | |
| NPPES Provider State | PA | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 481.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 33.0 | |
| Percent Opioid Claims | 6.86 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1063626190 |
| Last Name Of The Provider | DENLINGER |
| First Name Of The Provider | CRYSTAL |
| View All |
Similar Doctors
|
|
Dr. Naomi S. Balzer-Haas, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Diane M. Hershock, MD |
|
|
Dr. David L. Bajor, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anjana Ranganathan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carl June, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Bruce J. Giantonio, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Daniel G. Haller, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Tara Gangadhar, MD
This Doctor is OpenDoctor Recommended.
|